Scroll to top

Presentation to international porphyria patient group

8 February 2016

 

Clinuvel Pharmaceuticals Ltd (ASX: CUV; XETRA‐DAX: UR9; ADR: CLVLY) presented to an international porphyria  patient meeting, held in Rotterdam, the Netherlands, on February 6, 2016. The presentation and speaking notes are  appended to this announcement.

 

Download PDF for more

Author avatar
Clinuvel
We use cookies to give you the best experience.